Navigation Links
Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
Date:12/5/2007

hasone dose. The trial is currently enrolling eligible patients with primary or secondary (metastatic) brain tumors who have already completed one of two Phase III randomized, double-blind trials of XERECEPT(R) currently underway at 27 centers in the U.S., Canada, Australia and New Zealand.

""Side effects of high-dose corticosteroid treatment have a devastating effect on quality-of-life and potentially on life expectancy, and any option that significantly reduces the use of dexamethasone would be a major benefit to patients," said Dr. Patrick O'Connor, Head of Clinical Development at Celtic Pharma. "The interim data presented at SNO are promising and we remain optimistic about the prospects for XERECEPT(R)."

"Celtic Pharma also announced plans to initiate an imaging study, CPDS 0701, to assess more directly the effects of XERECEPT(R) on PBE. Sequential brain scans from some glioblastoma patients being treated with XERECEPT(R) suggest reduction of edema. The imaging study will aim to establish whether this observation can be substantiated over a larger patient population. The multicenter, open-label, randomized study will investigate the efficacy and safety of XERECEPT(R) for the reduction of PBE in patients with primary or metastatic brain tumors. The study is targeted to begin enrolling patients in early 2008 at investigational sites in the United States and Canada.

"Separately, Celtic Pharma announced the discontinuation of enrollment in study NTI 0302, a Phase III randomized, double-blind study comparing XERECEPT(R) to dexamethasone in first line treatment of symptoms associated with PBE in patients newly diagnosed with primary malignant glioma. The decision to discontinue enrollment for this trial was due to slower than anticipated recruitment and Celtic Pharma's conclusion that the new CPDS 0701 imaging study would be a more important contributor to the overall robustness of the XERECEPT(R) development program. No safety issues prompted thi
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015  With the heroin epidemic in ... heights, Jacksonville -based Lakeview Health drug ... is helping to explain why fentanyl is causing a ... to 50 times more potent than pharmaceutical grade heroin ... heroin, the risk of death skyrockets. "Fentanyl ...
(Date:8/28/2015)... According to a new market ... Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... 17,689.0 Million USD by 2020 at a CAGR of ... Browse 191 Tables and 38 F ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... Capacity and Production" report to their offering. ... Survey of Biopharmaceutical Manufacturing Capacity and Production is ... contract manufacturing organizations, current and projected future capacity ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 512th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... 1, 2011 Advanstar Communications, Inc., a ... the Fashion, Life Sciences and Powersports industries, announced today ... newly created position of Executive Vice President, Pharmaceutical/Science. ... Officer and Chief Administrative Officer roles, this new position ...
... FRANCISCO, March 1, 2011 Practice Fusion, ... community in the US, today announced Jason Portnoy as ... leading, free, cloud-based EMR to physicians; enabling charting, scheduling, ... a period of rapid expansion, bringing his deep expertise ...
Cached Medicine Technology:Veteran Executive Ron Wall Joins Advanstar Communications as Executive Vice President, Pharmaceutical/Science 2Former PayPal, Palantir Executive Jason Portnoy Joins Practice Fusion as CFO 2Former PayPal, Palantir Executive Jason Portnoy Joins Practice Fusion as CFO 3
(Date:8/30/2015)... ... August 30, 2015 , ... Scientists in France say asbestos exposure may ... digestive cancers. Surviving Mesothelioma has just posted an article on the new research. ... measured the cancer incidence among 2,024 French asbestos plant workers from 1978 to 2009. ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ... assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products International. ... your goals. Kathleen graduated from Florida State University with a Bachelor of ...
(Date:8/29/2015)... ... 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director ... Foundation) will present an educational program titled “Asbestos and Your Health.” , The two ... (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, ...
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now available on ... was required to qualify for free standard shipping,” said Jennifer Ramirez, the public relations ... of the item’s selling price.” , With competitive pricing in the e-commerce market for ...
(Date:8/29/2015)... ... 2015 , ... The popular television program VOICES IN AMERICA, hosted by legendary ... be devoting an entire short segment to the subject of diabetes. Diabetes is a ... a daily basis, but recent advancements in medical science may prove to be a ...
Breaking Medicine News(10 mins):Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2
... will soon have the opportunity to take part in ... the autoimmune disease, ankylosing spondylitis. Approximately 200 patients will ... aims to merge the latest molecular discoveries published by ... medical expertise of physicians and researchers at West China ...
... glaucoma and other conditions , , ... times a day can be difficult for patients to do, and because ... the dose is actually absorbed by the eye. Now, researchers led by ... Delivery at Children,s Hospital Boston, have developed special contact lenses that can ...
... , , , ... Allscripts (Nasdaq: MDRX ), the leader in software, ... Medfusion, the leader in patient-to-provider online communication solutions, today announced ... for Allscripts Electronic Health Record (EHR) and Practice Management clients ...
... 21 /PRNewswire-USNewswire / -- Representatives from leading national ... to honor the 2009 winners of the National Family ... and MetLife Foundation. The event recognized community-based programs supporting ... responsiveness to caregiver needs. , ...
... they,d prefer more flex time and balance in life, , TUESDAY, ... all again, most female surgeons would choose the same career path, ... in the July issue of Archives of Surgery , revealed ... because of their rigorous training and work schedule. , Few female ...
... combined with air pollution, smoking, it raises chances of condition, ... pollution from cars can increase a child,s chances of developing ... get even higher, a new study finds. , For children ... risk, parental stress also increases the risk for asthma, the ...
Cached Medicine News:Health News:Study aims to induce recovery from ankylosing spondylitis 2Health News:A Drug-Dispensing Contact Lens 2Health News:A Drug-Dispensing Contact Lens 3Health News:Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 2Health News:Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 3Health News:Allscripts and Medfusion Partner to Provide Patient Portal to Physician Practices Nationwide 4Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 2Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 3Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 4Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 5Health News:Female Surgeons Like What They Do, Survey Finds 2Health News:Parental Stress Boosts Kids' Asthma Risk 2Health News:Parental Stress Boosts Kids' Asthma Risk 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: